Alaunos Therapeutics (TCRT) Other Non Operating Income (2009 - 2026)
Alaunos Therapeutics' (TCRT) quarterly Other Non Operating Income came in at $6000.0 in Q1 2026, down 68.42% YoY from $19000.0 in Q1 2025, and down 57.14% on a QoQ basis from $14000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Other Non Operating Income (2009 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 18 years of Other Non Operating Income data on file, last reported at $6000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 68.42% year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67000.0 (down 27.17% YoY) and the FY2025 annual result came in at $80000.0, down 39.85% from the prior year.
- Other Non Operating Income eased to $6000.0 in Q1 2026, from $14000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $477000.0 in Q1 2023 to a low of -$20000.0 in Q1 2022.
- A 5-year average of $105411.8 and a median of $37000.0 in 2024 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 12400.0% in 2022, down 322.22% in 2022.
- Tracing TCRT's Other Non Operating Income over 5 years: stood at $250000.0 in 2022, then sank by 57.6% to $106000.0 in 2023, then plunged by 87.74% to $13000.0 in 2024, then rose by 7.69% to $14000.0 in 2025, then sank by 57.14% to $6000.0 in 2026.
- The last three Other Non Operating Income figures came in at $6000.0 (Q1 2026), $14000.0 (Q4 2025), and $28000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 60,000.00 |
| Dec 31, 2023 | 106,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 277,000.00 |
| Mar 31, 2023 | 477,000.00 |
| Dec 31, 2022 | 250,000.00 |
| Sep 30, 2022 | 254,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | -20,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | -31,000.00 |